[ad_1]
Dublin, January 4, 2022 (Global News Agency) – “2014-2021 Global Autoimmune Cooperation: Transaction Trends, Participants and Finance” Report has been added to ResearchAndMarkets.com supply.
Global Autoimmune Partnering 2014 to 2021 provides a complete collection of autoimmune disease transactions signed between the world’s pharmaceutical and biotech companies since 2014.
Most of the transactions included in the report occurred when the licensee obtained rights or options for the licensor’s product or technology. Nowadays, these transactions are often multi-component, including collaborative R&D and commercialization of outcome elements.
The report allows readers to understand the comprehensive autoimmune disease transaction trend, the main participants and the highest transaction value, so as to understand the company’s current approach to autoimmune disease transactions, reasons and conditions.
The report introduces the value of financial transaction terms of autoimmune transactions, which can be listed by overall title value, advance payment, milestones, and royalties, allowing readers to analyze and measure the value of current transactions.
The first few chapters of this report provide directions for autoimmune trading trends.
Chapter 1 introduces the report.
Chapter 2 outlines the trends in autoimmune trading since 2014, covering trends divided by year, transaction type, development stage, technology type, and treatment indications.
Chapter 3 includes an analysis of financial transaction terms covering title value, advance payment, milestone payment, and royalties.
Chapter 4 reviews the major autoimmune transactions since 2014. Transactions are listed by title value. This chapter includes the top 25 most active autoimmune transaction matchmakers, as well as…
The full story on Benzinga.com
[ad_2]
Source link
